Calculations of Factor VIII in vivo Recovery and Half‐life
- 1 December 1984
- journal article
- Published by Wiley in Scandinavian Journal of Haematology
- Vol. 33 (S40), 165-174
- https://doi.org/10.1111/j.1600-0609.1984.tb02560.x
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- FACTOR VIII STANDARDISATIONThe Lancet, 1983
- Étude d'un concentré thérapeutique de facteur VIII/vWf préparé en circuit closRevue Française de Transfusion et Immuno-hématologie, 1982
- Factor VIII:C and VIII:CAg Response in Patients with Haemophilia A and von Willebrand's Disease after Administration of Different Factor VIII Concentrates or PlasmaBritish Journal of Haematology, 1981
- In vitro and in vivo Characterization of Factor VIII PreparationsVox Sanguinis, 1980
- Factor VIII (Antihemophilic Globulin)Seminars in Thrombosis and Hemostasis, 1980
- Twice weekly prophylactic therapy in haemophilia A.Journal of Clinical Pathology, 1977
- Survival of Transfused Factor VIII in Hemophilic Patients Treated with Epsilon Aminocaproic AcidTransfusion, 1976
- Do you need a pharmacokinetic model, and, if so, which one?Journal of Pharmacokinetics and Biopharmaceutics, 1975
- Early treatment of hemophilic hemarthroses withminimal dose of new factor VIII concentrateThe Journal of Pediatrics, 1974
- Factor 8 concentrates in outpatient therapyPublished by American Medical Association (AMA) ,1972